Hyaluronic Acid Products Market to Hit US$ 18.32 Billion by 2031, Says Growth Plus Reports

Newark, New Castle, USA, July 03, 2023 (GLOBE NEWSWIRE) — A recent report by Growth Plus Reports estimated the global hyaluronic acid products market to be worth US$ 9.8 billion in 2022. From 2023 to 2031, market revenue is expected to grow at a CAGR of 8.7%, reaching US$ 18.32 billion. The most successful strategies, market trends, the competitive environment, significant drivers and opportunities, statistical data, market size, and revenue are all included in the report. 

Key Takeaways: 

• Social media and beauty influencers are driving market revenue growth.
• The launch of novel products by market players is boosting the revenue share. 
• Significant R&D activities with hyaluronic acid create a string product pipeline. 

Download the Free Sample Report Now @ https://www.growthplusreports.com/inquiry/request-sample/hyaluronic-acid-products-market/8501

                                    Hyaluronic Acid Products Market Scope

Market Drivers: 
The rising geriatric population and rising demand for anti-aging products drive market revenue growth of hyaluronic acid products. Furthermore, technical advancements and innovations of new hyaluronic acid products are expanding market revenue growth. 

Market Segmentation: 
Growth plus reports have analyzed the global hyaluronic acid products market from perspectives such as application, end-user, and region. 

Application Segmentation: 
Based on the application, the global hyaluronic acid products market is segmented into dermal fillers, osteoarthritis, ophthalmic, and vesicoureteral reflux.

The osteoarthritis segment dominates the hyaluronic acid products market with the largest revenue share. The rising prevalence of osteoarthritis increases the demand for effective treatment in pain relieving, and improving joint functions, boosting the segment’s revenue growth. The dermal filler segment is expected to rise with significant revenue share during the forecast period due to its wide applications in enhancing facial features. 

End-User Segmentation: 
Based on end-user, the global hyaluronic acid products market is segmented into the personal care industry, pharmaceutical industry, and others.

The personal care segment accounts for the largest revenue share in the hyaluronic acid products market. This high revenue share is attributed to a wide range of products, such as serums, masks, moisturizers, and anti-aging creams containing hyaluronic acid. These products are popular among consumers looking for an effective and safe solution to improve the health and appearance of their skin. 

Request for Customization – https://www.growthplusreports.com/inquiry/customization/hyaluronic-acid-products-market/8501

Regional Growth Dynamics: 
Based on regions, the global hyaluronic acid products market has been segmented into North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa. 

North America is expected to account for the largest market revenue share during the forecast period. This rise in revenue share is attributed to the strong demand for hyaluronic acid products, increasing demand for anti-aging products, and increasing interest in natural and organic skincare products. 

Competitive Landscape:
The prominent players operating in the global hyaluronic acid products market are:

• Lifecore Biomedical
• Salix Pharmaceuticals
• F. Hoffmann-La Roche Ltd
• Zimmer Biomet
• HTL Biotechnology
• Lifecore Biomedical, Llc.
• Allergan plc (AbbVie)
• Sanofi S.A.
• Anika Therapeutics, Inc.
• Contipro AS
• Smith & Nephew Plc
• Galderma Laboratories L.P.
• Ferring B.V.
• Seikagaku Corporation

New product releases and higher R&D spending are two main techniques used by significant players to get a larger market revenue share. Both domestic and international companies that manufacture hyaluronic acid products are concentrating on launching unique products while expanding their R&D efforts and monitoring the entry of new competitors. 

Recent Advancements: 

• In February 2023, a filler from Maypharm, called MayFill, features lidocaine for a comfortable application and multi-layered phasic hyaluronic acid based on novel R2 technology (rotation and revolution). Two layers of multi-layered Phasic hyaluronic acid fillers coexist in the body, gradually producing even more natural effects. 

• In March 2021, Hyaluronic acid was introduced in three distinct forms by Royal DSM. DSM expands its offering of hyaluronic acid with the introduction of the HYA-ACT line to address consumer demand for less intrusive, dependable, and potent cosmetic care products. The three hyaluronic acid types offer important advantages, supply customers’ desired efficacy, and give them the desired increase in appearance.

Table of Content

1. INTRODUCTION
   1. Market Ecosystem
   2. Timeline Under Consideration
      1. Historical Years – 2021
      2. Base Year – 2022
      3. Forecast Years – 2023 to 2031
   3. Currency Used in the Report
2. RESEARCH METHODOLOGY 
   1. Research Approach
   2. Data Collection Methodology
   3. Data Sources 
      1. Secondary Sources 
      2. Primary Sources
   4. Market Estimation Approach
      1. Bottom Up
      2. Top Down 
   5. Market Forecasting Model
   6. Limitations and Assumptions
3. PREMIUM INSIGHTS
   1. Current Market Trends (COVID-19 Perspective)
   2. Key Players & Competitive Positioning (2022) 
4. MARKET DYNAMICS
   1. Drivers
   2. Restraints/Challenges
   3. Opportunities
5. GLOBAL HYALURONIC ACID PRODUCTS MARKET – ANALYSIS & FORECAST, BY APPLICATION
   1. Dermal Fillers
   2. Osteoarthritis
   3. Ophthalmic
   4. Vesicoureteral reflux
6. GLOBAL HYALURONIC ACID PRODUCTS MARKET – ANALYSIS & FORECAST, BY END-USER
   1. Personal Care Industry
   2. Pharmaceutical Industry
   3. Others 

HYALURONIC ACID PRODUCTS MARKET TOC

Buy this Premium Research Report: https://www.growthplusreports.com/checkout-8501

VALUE PROPOSITIONS RELATED TO THE REPORT:

• Powered with Complimentary Analyst Hours and Expert Interviews with Each Report
• Comprehensive quantitative and qualitative insights at segment and sub-segment level
• Covid 19 impact trends and perspective
• Granular insights at global/regional/country level
• Deep-rooted insights on market dynamics (drivers, restraints, opportunities) and business environment
• Blanket coverage on competitive landscape
• Winning imperatives
• Exhaustive coverage on ‘Strategic Developments’ registered by leading players of the market.

CUSTOMIZATION OPTIONS:

• Distributor Landscape Assessment
• Pricing Intelligence
• Customer Base Assessment
• Investment & Initiatives Analysis
• ‘Business Profile’ of Key Players

Schedule a call with our analyst: https://appoint.ly/s/salesZ3Jvd3RocGx1c3JlcG9ydHMuY29t/introduction

Visit our report store at – https://www.growthplusreports.com/report-store

Browse more latest healthcare reports:

Combination Antihypertensives Market by Type (ACE Inhibitors with Calcium Channel blocking agents, ACE inhibitors with thiazides), Distribution Channel (Hospital Pharmacies, Retail Pharmacies) – Global Outlook & Forecast 2023-2031

Hydatid Disease Treatment Market by Drug (Mebendazole, Albendazole), Distribution Channel (Hospital Pharmacies, Retail Pharmacies) – Global Outlook & Forecast 2023-2031

High-Grade Neuroendocrine Neoplasms Market by Drug Class (Platinum Coordination Complexes, Somatostatin Analogues), Distribution Channel (Hospital Pharmacies, Retail Pharmacies) – Global Outlook & Forecast 2023-2031

Postoperative Pain Medication Market by Drug Class (NSAIDS, Opioids), Route of Administration (Oral, Parenteral), Distribution Channel (Hospital Pharmacies, Retail Pharmacies) – Global Outlook & Forecast 2023-2031

Mast Cell Stabilizers Market by Type (Mastocytosis, Seasonal Allergic Rhinitis, and Perennial Allergic Conjunctivitis), Distribution Channel (Hospital Pharmacies, Retail Pharmacies) – Global Outlook and Forecast 2023-2031

Unleashing the Power of Innovation in Med Tech:  https://growthplusmedtechroundup.com

About Us:

Growth Plus Reports is part of GRG Health, a global healthcare knowledge service company. We are proud members of EPhMRA (European Pharmaceutical Marketing Research Association).

Growth Plus portfolio of services draws on our core capabilities of secondary & primary research, market modelling & forecasting, benchmarking, analysis and strategy formulation to help clients create scalable, ground-breaking solutions that prepare them for future growth and success.

We were awarded by the prestigious CEO Magazine as “Most Innovative Healthcare Market Research Company in 2020”.